Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients

Universitaire Ziekenhuizen KU Leuven110 enrolled

Overview

The goal is to study the biology of aging in breast cancer patients, and to study the impact of chemotherapy on aging related blood biomarkers.

Study Type

OBSERVATIONAL

Enrollment

110

Sex: FEMALEMin age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 70 years or older * Female * Early breast cancer * Candidate for systemic adjuvant therapy

Jules Bordet Institute

Brussels, Belgium

University Hospitals Leuven

Leuven, Belgium

the primary question is whether Chemotherapy affects biological aging markers, such as telomere length and immune status

Time frame: 2 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.